90794-32-4

Basic information

• Product Name: Acetic acid, (2-iodophenoxy)-, ethyl ester
• Synonyms: 2-([(ethoxycarbonyl)methylene]oxy)-1-iodobenzene;ethyl (2-iodophenoxy)acetate;(2-iodo-phenoxy)-acetic acid ethyl ester;Acetic acid,(2-iodophenoxy)-,ethyl ester;ethyl 2-(2-iodophenoxy)acetic acid
• CAS NO: 90794-32-4
• Molecular Formula: C10H11IO3
• Molecular Weight: 306.1
• Mol File: 90794-32-4.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 148-150 °C(Press: 0.7 Torr)
• Density: 1.623±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Acetic acid, (2-iodophenoxy)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, (2-iodophenoxy)-, ethyl ester(90794-32-4)
• EPA Substance Registry System: Acetic acid, (2-iodophenoxy)-, ethyl ester(90794-32-4)

Safety Data

• Hazardous Substances Data: 90794-32-4(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 1878-92-8 2-(2-iodophenoxy)acetic acid 
• 533-58-4 2-Iodophenol 
• 105-36-2 ethyl bromoacetate 
• 106-49-0 p-toluidine 
• 105-39-5 chloroacetic acid ethyl ester 

Downstream Products

• 203723-14-2 1-(2-Hydroxy-phenyl)-4-(2-iodo-phenoxy)-butane-1,3-dione 
• 120045-73-0 2-(2'-iodophenoxymethyl)chromen-4-one 
• 805238-26-0 [2-(3-methoxy-prop-1-ynyl)-phenoxy]-acetic acid ethyl ester 
• 1265140-89-3 C₂₅H₂₅NO₅ 
• 1373496-79-7 C₂₂H₂₃N₃O₆ 
• 1373496-69-5 C₁₀H₈O₃ 
• 1373496-70-8 C₁₄H₁₇NO₂ 
• 1373496-80-0 C₂₅H₃₁N₅O₄ 
• 1373496-81-1 C₂₃H₂₇N₅O₄ 
• 1373496-77-5 C₁₆H₂₀N₂O₃ 
• 1373496-83-3 C₃₃H₄₅N₇O₆ 
• 1373496-67-3 ethyl 2-(2-ethynylphenoxy)acetate 
• 1373496-66-2 ethyl (2-((trimethylsilyl)ethynyl)phenoxy)acetate 
• 1878-92-8 2-(2-iodophenoxy)acetic acid 

Relevant articles and documents

Synthesis of carbonylated heteroaromatic compounds: Via visible-light-driven intramolecular decarboxylative cyclization of o -alkynylated carboxylic acids

An efficient strategy for the easy access to carbonylated heteroaromatic compounds has been developed via a visible-light-promoted intramolecular decarboxylative cyclization reaction of o-alkynylated carboxylic acids. This method is characterized by its b

Synthesis and biological evaluation of new quinoxaline derivatives of ICF01012 as melanoma-targeting probes

The aim of this study was the synthesis and pharmacokinetic selection of a best melanin-targeting ligand for addressing anticancer agents to pigmented melanoma. Seven quinoxaline carboxamide derivatives were synthesized and radiolabeled with iodine-125. Biodistribution studies of compounds [ 125I]1a-g performed in melanoma-bearing mice tumor showed significant tumor uptake (range 2.43-5.68%ID/g) within 1 h after i.v. injection. Fast clearance of the radioactivity from the nontarget organs mainly via the urinary system gave high tumor-to-blood and tumor-to-muscle ratios. Given its favorable clearance and high tumor-melanoma uptake at 72 h, amide 1d was the most promising melanoma-targeting ligand in this series. Compound 1d will be used as building block for the design of new melanoma-selective drug delivery systems.

PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE DERIVATIVES AS PDE9 INHIBITORS

A compound of the general formula (I) wherein R1 is selected from the group consisting of phenyl unsubstituted or substituted with 1 to 3 substituents selected from F, Cl, Br, I, CN, -O-C1-C3-alkyl, fluorinated -O-C1-C3-alkyl, -(CH2)mOH and 5-membered heterocyclic group with 1 or 2 heteroatoms selected from N, O and S; and 6- or 10-membered heteroaryl with 1 to 3 heteroatoms selected from O, N and S; R2 and R3 independently of each other represent H atom or straight or branched C1-C3 alkyl; R4 is selected from the group consisting of 4- to 6- membered cycloalkyl, wherein one of carbon atoms can be replaced by O atom, and which is unsubstituted or substituted with one or two halogen atoms,and straight or branched C1-C4 alkyl; Q represents a bond or C1-C3-alkylene, which can be optionally substituted by one to three C1-C3-alkyls; X is selected from the group consisting of O, NR5, and S(O)p; R5 represents H atom or C1-C3alkyl; m is 1, 2 or 3; p is 0, 1 or 2; and salts thereof, for use as a medicament, in particular for treating cognitive function disorders and neurodegenerative diseases.